These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 20706736

  • 1. Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi).
    Le Sueur C, Bour S, Schaper R.
    Parasitol Res; 2010 Nov; 107(6):1463-9. PubMed ID: 20706736
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study.
    Segev G, Rojas A, Lavy E, Yaffe M, Aroch I, Baneth G.
    Parasit Vectors; 2018 Mar 05; 11(1):127. PubMed ID: 29506575
    [Abstract] [Full Text] [Related]

  • 3. The efficacy of a topically applied imidacloprid 10 % / moxidectin 2.5 % formulation (Advocate®, Advantage® Multi, Bayer) against Immature and Adult Spirocerca lupi worms in experimentally infected dogs.
    Austin CM, Kok DJ, Crafford D, Schaper R.
    Parasitol Res; 2013 Aug 05; 112 Suppl 1():91-108. PubMed ID: 23779222
    [Abstract] [Full Text] [Related]

  • 4. The use of milbemycin oxime in a prophylactic anthelmintic programme to protect puppies, raised in an endemic area, against infection with Spirocerca lupi.
    Kok DJ, Williams EJ, Schenker R, Archer NJ, Horak IG.
    Vet Parasitol; 2010 Dec 15; 174(3-4):277-84. PubMed ID: 20869809
    [Abstract] [Full Text] [Related]

  • 5. Comparative evaluation of the prophylactic activity of a slow-release insecticide collar and a moxidectin spot-on formulation against Thelazia callipaeda infection in naturally exposed dogs in France.
    Lechat C, Siméon N, Pennant O, Desquilbet L, Chahory S, Le Sueur C, Guillot J.
    Parasit Vectors; 2015 Feb 10; 8():93. PubMed ID: 25884443
    [Abstract] [Full Text] [Related]

  • 6. Detection and quantification of Spirocerca lupi by HRM qPCR in fecal samples from dogs with spirocercosis.
    Rojas A, Segev G, Markovics A, Aroch I, Baneth G.
    Parasit Vectors; 2017 Sep 19; 10(1):435. PubMed ID: 28927435
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the efficacy of monthly oral administration of afoxolaner plus milbemycin oxime (NexGard Spectra(®), Merial) in the prevention of adult Spirocerca lupi establishment in experimentally infected dogs.
    Beugnet F, Crafford D, de Vos C, Kok D, Larsen D, Fourie J.
    Vet Parasitol; 2016 Aug 15; 226():150-61. PubMed ID: 27514901
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs.
    Otranto D, Colella V, Crescenzo G, Solari Basano F, Nazzari R, Capelli G, Petry G, Schaper R, Pollmeier M, Mallia E, Dantas-Torres F, Lia RP.
    Vet Parasitol; 2016 Aug 30; 227():118-21. PubMed ID: 27523947
    [Abstract] [Full Text] [Related]

  • 9. Spirocerca lupi in dogs: prophylactic effect of doramectin.
    Lavy E, Harrus S, Mazaki-Tovi M, Bark H, Markovics A, Hagag A, Aizenberg I, Aroch I.
    Res Vet Sci; 2003 Dec 30; 75(3):217-22. PubMed ID: 13129670
    [Abstract] [Full Text] [Related]

  • 10. Treatment of dog thelaziosis caused by Thelazia callipaeda (Spirurida, Thelaziidae) using a topical formulation of imidacloprid 10% and moxidectin 2.5%.
    Bianciardi P, Otranto D.
    Vet Parasitol; 2005 Apr 20; 129(1-2):89-93. PubMed ID: 15817208
    [Abstract] [Full Text] [Related]

  • 11. Potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.
    Traversa D, Mazzi A, Di Cesare A, Famigli Bergamini P, Fracassi F, Fanini G, Aste G, Pampurini F, Boari A.
    Parasitol Res; 2013 Nov 20; 112(11):3753-6. PubMed ID: 23925446
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of doramectin for the treatment of experimental canine spirocercosis.
    Lavy E, Aroch I, Bark H, Markovics A, Aizenberg I, Mazaki-Tovi M, Hagag A, Harrus S.
    Vet Parasitol; 2002 Oct 16; 109(1-2):65-73. PubMed ID: 12383626
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
    Petry G, Genchi M, Schmidt H, Schaper R, Lawrenz B, Genchi C.
    Parasitol Res; 2015 Aug 16; 114 Suppl 1():S131-44. PubMed ID: 26152414
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of milbemycin oxime against pre-adult Spirocerca lupi in experimentally infected dogs.
    Kok DJ, Schenker R, Archer NJ, Horak IG, Swart P.
    Vet Parasitol; 2011 Apr 19; 177(1-2):111-8. PubMed ID: 21168275
    [Abstract] [Full Text] [Related]

  • 15. Experimental infection with Ancylostoma ceylanicum in dogs and efficacy of a spot on combination containing imidacloprid 10% and moxidectin 2.5% (Advocate/Advantage Multi, Bayer Animal Health).
    Taweethavonsawat P, Chungpivat S, Satranarakun P, Traub RJ, Schaper R.
    Parasitol Res; 2010 May 19; 106(6):1499-502. PubMed ID: 20349196
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
    Krieger K, Heine J, Dumont P, Hellmann K.
    Parasitol Res; 2005 Oct 19; 97 Suppl 1():S81-S88. PubMed ID: 16228280
    [Abstract] [Full Text] [Related]

  • 17. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.
    Arther RG, Bowman DD, Slone RL, Travis LE.
    Parasitol Res; 2005 Oct 19; 97 Suppl 1():S76-S80. PubMed ID: 16228279
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens.
    Hellmann K, Heine J, Braun G, Paran-Dobesova R, Svobodova V.
    Parasitol Res; 2011 Aug 19; 109 Suppl 1():S77-86. PubMed ID: 21739377
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of orally administered fluralaner (Bravecto™) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs.
    Fourie JJ, Liebenberg JE, Horak IG, Taenzler J, Heckeroth AR, Frénais R.
    Parasit Vectors; 2015 Mar 28; 8():187. PubMed ID: 25881320
    [Abstract] [Full Text] [Related]

  • 20. Canine spirocercosis.
    Mylonakis ME, Rallis T, Koutinas AF.
    Compend Contin Educ Vet; 2008 Feb 28; 30(2):111-6. PubMed ID: 18368693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.